CLPTM1L anticorps (Middle Region)
-
- Antigène Voir toutes CLPTM1L Anticorps
- CLPTM1L (CLPTM1-Like (CLPTM1L))
-
Épitope
- Middle Region
-
Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp CLPTM1L est non-conjugé
-
Application
- Western Blotting (WB)
- Specificité
- CLPTM1 L antibody was raised against the middle region of CLPTM1
- Purification
- Affinity purified
- Immunogène
- CLPTM1 L antibody was raised using the middle region of CLPTM1 corresponding to a region with amino acids KAFTYKAFNTFIDDVFAFIITMPTSHRLACFRDDVVFLVYLYQRWLYPVD
- Top Product
- Discover our top product CLPTM1L Anticorps primaire
-
-
- Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Commentaires
-
CLPTM1L Blocking Peptide, catalog no. 33R-4238, is also available for use as a blocking control in assays to test for specificity of this CLPTM1L antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CLPTM0 antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Stock
- 4 °C/-20 °C
- Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Antigène
- CLPTM1L (CLPTM1-Like (CLPTM1L))
- Autre désignation
- CLPTM1L (CLPTM1L Produits)
- Sujet
- CLPTM1L enhances cisplatin-mediated apoptosis, when overexpressed.
- Poids moléculaire
- 62 kDa (MW of target protein)
-